The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens

Wen Chen, Jose Jeronimo, Fang Hui Zhao, You Lin Qiao, Melissa Valdez, Xun Zhang, Le Ni Kang, Pooja Bansil, Proma Paul, Ping Bai, Roger Peck, Jing Li, Feng Chen, Mark H. Stoler, Philip E. Castle

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: careHPV is a new, lower-cost DNA test for human papillomavirus (HPV). There are limited analytic comparisons of careHPV against a referent HPV DNA test like Hybrid Capture 2 (HC2). Objective: To assess the test agreement between careHPV and HC2 on self- and clinician-collected specimens. Study design: In a population of 7541 women living in rural China, women provided a self-collected (sc) and two clinician-collected (cc) specimens and underwent visual inspection after acetic acid (VIA). The sc specimen and one cc specimen were tested by careHPV and HC2; a random subset of specimens was tested for HPV genotypes. Results: The percent positive on cc specimens and sc specimens was 14.69% and 14.97% for careHPV, respectively, and 15.05% and 18.53% for HC2, respectively; HC2 testing of sc specimens was more likely to test positive than other combinations of tests and specimens (p<0.0001 for all comparisons). The agreement between different tests on the same specimens (kappa=0.787 and 0.691 for cc and sc specimens, respectively) was better than the same test on different specimens (kappa=0.653 and 0.649 for HC2 and careHPV, respectively). Disagreement between the same test on different specimens increased with increasing participant age (ptrend=0.0001 for HC2 and 0.002 for careHPV). HC2-positive/careHPV-negative specimens were more likely to test positive for non-carcinogenic HPV genotype than test HPV negative whereas the converse was true for HC2-negative/careHPV-positive specimens. Discussion: The agreement for HPV DNA detection between careHPV and HC2 was good to very good.

Original languageEnglish (US)
Pages (from-to)553-557
Number of pages5
JournalJournal of Clinical Virology
Volume61
Issue number4
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

DNA
Human Papillomavirus DNA Tests
Genotype
Acetic Acid
China
Costs and Cost Analysis
Population

Keywords

  • Cervical cancer
  • Cervical intraepithelial neoplasia (CIN)
  • Human papillomavirus (HPV)
  • Visual inspection after acetic acid (VIA)

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases
  • Medicine(all)

Cite this

The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens. / Chen, Wen; Jeronimo, Jose; Zhao, Fang Hui; Qiao, You Lin; Valdez, Melissa; Zhang, Xun; Kang, Le Ni; Bansil, Pooja; Paul, Proma; Bai, Ping; Peck, Roger; Li, Jing; Chen, Feng; Stoler, Mark H.; Castle, Philip E.

In: Journal of Clinical Virology, Vol. 61, No. 4, 2014, p. 553-557.

Research output: Contribution to journalArticle

Chen, W, Jeronimo, J, Zhao, FH, Qiao, YL, Valdez, M, Zhang, X, Kang, LN, Bansil, P, Paul, P, Bai, P, Peck, R, Li, J, Chen, F, Stoler, MH & Castle, PE 2014, 'The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens', Journal of Clinical Virology, vol. 61, no. 4, pp. 553-557. https://doi.org/10.1016/j.jcv.2014.09.018
Chen, Wen ; Jeronimo, Jose ; Zhao, Fang Hui ; Qiao, You Lin ; Valdez, Melissa ; Zhang, Xun ; Kang, Le Ni ; Bansil, Pooja ; Paul, Proma ; Bai, Ping ; Peck, Roger ; Li, Jing ; Chen, Feng ; Stoler, Mark H. ; Castle, Philip E. / The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens. In: Journal of Clinical Virology. 2014 ; Vol. 61, No. 4. pp. 553-557.
@article{d1664f9be4644a4bada1c08b167997a7,
title = "The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens",
abstract = "Background: careHPV is a new, lower-cost DNA test for human papillomavirus (HPV). There are limited analytic comparisons of careHPV against a referent HPV DNA test like Hybrid Capture 2 (HC2). Objective: To assess the test agreement between careHPV and HC2 on self- and clinician-collected specimens. Study design: In a population of 7541 women living in rural China, women provided a self-collected (sc) and two clinician-collected (cc) specimens and underwent visual inspection after acetic acid (VIA). The sc specimen and one cc specimen were tested by careHPV and HC2; a random subset of specimens was tested for HPV genotypes. Results: The percent positive on cc specimens and sc specimens was 14.69{\%} and 14.97{\%} for careHPV, respectively, and 15.05{\%} and 18.53{\%} for HC2, respectively; HC2 testing of sc specimens was more likely to test positive than other combinations of tests and specimens (p<0.0001 for all comparisons). The agreement between different tests on the same specimens (kappa=0.787 and 0.691 for cc and sc specimens, respectively) was better than the same test on different specimens (kappa=0.653 and 0.649 for HC2 and careHPV, respectively). Disagreement between the same test on different specimens increased with increasing participant age (ptrend=0.0001 for HC2 and 0.002 for careHPV). HC2-positive/careHPV-negative specimens were more likely to test positive for non-carcinogenic HPV genotype than test HPV negative whereas the converse was true for HC2-negative/careHPV-positive specimens. Discussion: The agreement for HPV DNA detection between careHPV and HC2 was good to very good.",
keywords = "Cervical cancer, Cervical intraepithelial neoplasia (CIN), Human papillomavirus (HPV), Visual inspection after acetic acid (VIA)",
author = "Wen Chen and Jose Jeronimo and Zhao, {Fang Hui} and Qiao, {You Lin} and Melissa Valdez and Xun Zhang and Kang, {Le Ni} and Pooja Bansil and Proma Paul and Ping Bai and Roger Peck and Jing Li and Feng Chen and Stoler, {Mark H.} and Castle, {Philip E.}",
year = "2014",
doi = "10.1016/j.jcv.2014.09.018",
language = "English (US)",
volume = "61",
pages = "553--557",
journal = "Journal of Clinical Virology",
issn = "1386-6532",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens

AU - Chen, Wen

AU - Jeronimo, Jose

AU - Zhao, Fang Hui

AU - Qiao, You Lin

AU - Valdez, Melissa

AU - Zhang, Xun

AU - Kang, Le Ni

AU - Bansil, Pooja

AU - Paul, Proma

AU - Bai, Ping

AU - Peck, Roger

AU - Li, Jing

AU - Chen, Feng

AU - Stoler, Mark H.

AU - Castle, Philip E.

PY - 2014

Y1 - 2014

N2 - Background: careHPV is a new, lower-cost DNA test for human papillomavirus (HPV). There are limited analytic comparisons of careHPV against a referent HPV DNA test like Hybrid Capture 2 (HC2). Objective: To assess the test agreement between careHPV and HC2 on self- and clinician-collected specimens. Study design: In a population of 7541 women living in rural China, women provided a self-collected (sc) and two clinician-collected (cc) specimens and underwent visual inspection after acetic acid (VIA). The sc specimen and one cc specimen were tested by careHPV and HC2; a random subset of specimens was tested for HPV genotypes. Results: The percent positive on cc specimens and sc specimens was 14.69% and 14.97% for careHPV, respectively, and 15.05% and 18.53% for HC2, respectively; HC2 testing of sc specimens was more likely to test positive than other combinations of tests and specimens (p<0.0001 for all comparisons). The agreement between different tests on the same specimens (kappa=0.787 and 0.691 for cc and sc specimens, respectively) was better than the same test on different specimens (kappa=0.653 and 0.649 for HC2 and careHPV, respectively). Disagreement between the same test on different specimens increased with increasing participant age (ptrend=0.0001 for HC2 and 0.002 for careHPV). HC2-positive/careHPV-negative specimens were more likely to test positive for non-carcinogenic HPV genotype than test HPV negative whereas the converse was true for HC2-negative/careHPV-positive specimens. Discussion: The agreement for HPV DNA detection between careHPV and HC2 was good to very good.

AB - Background: careHPV is a new, lower-cost DNA test for human papillomavirus (HPV). There are limited analytic comparisons of careHPV against a referent HPV DNA test like Hybrid Capture 2 (HC2). Objective: To assess the test agreement between careHPV and HC2 on self- and clinician-collected specimens. Study design: In a population of 7541 women living in rural China, women provided a self-collected (sc) and two clinician-collected (cc) specimens and underwent visual inspection after acetic acid (VIA). The sc specimen and one cc specimen were tested by careHPV and HC2; a random subset of specimens was tested for HPV genotypes. Results: The percent positive on cc specimens and sc specimens was 14.69% and 14.97% for careHPV, respectively, and 15.05% and 18.53% for HC2, respectively; HC2 testing of sc specimens was more likely to test positive than other combinations of tests and specimens (p<0.0001 for all comparisons). The agreement between different tests on the same specimens (kappa=0.787 and 0.691 for cc and sc specimens, respectively) was better than the same test on different specimens (kappa=0.653 and 0.649 for HC2 and careHPV, respectively). Disagreement between the same test on different specimens increased with increasing participant age (ptrend=0.0001 for HC2 and 0.002 for careHPV). HC2-positive/careHPV-negative specimens were more likely to test positive for non-carcinogenic HPV genotype than test HPV negative whereas the converse was true for HC2-negative/careHPV-positive specimens. Discussion: The agreement for HPV DNA detection between careHPV and HC2 was good to very good.

KW - Cervical cancer

KW - Cervical intraepithelial neoplasia (CIN)

KW - Human papillomavirus (HPV)

KW - Visual inspection after acetic acid (VIA)

UR - http://www.scopus.com/inward/record.url?scp=84922744895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922744895&partnerID=8YFLogxK

U2 - 10.1016/j.jcv.2014.09.018

DO - 10.1016/j.jcv.2014.09.018

M3 - Article

C2 - 25453572

AN - SCOPUS:84922744895

VL - 61

SP - 553

EP - 557

JO - Journal of Clinical Virology

JF - Journal of Clinical Virology

SN - 1386-6532

IS - 4

ER -